Ryan Specialty Holdings Inc. research snapshot
RYAN AI stock analysis currently reads Ryan Specialty Holdings as a well-positioned specialty insurance broker benefiting from structural growth in the excess and surplus lines market, where it competes through wholesale brokerage, binding authority, and underwriting management. The stock closed near $44.16 on July 31, 2026, with a Class A market value near $5.72 billion on about 129.47 million shares. Q2 2026 revenue grew 7.2% to $916.65 million, adjusted EPS of $0.74 beat estimates by roughly 23%, and adjusted EBITDA of $326.9 million came in well ahead of consensus, while the company announced a $600 million share repurchase program. The specialty insurance model generates gross margins above 90%, but adjusted operating margin fell to 19.7% from 22.3% a year earlier, free cash flow margin dropped sharply, and 2026 organic growth guidance points to the high end of mid-single digits amid pricing headwinds. The RYAN AI stock forecast treats the company as a quality compounder, but a trailing GAAP P/E near 57x and decelerating growth leave limited room for error if the pricing cycle turns.
Current price
$44.16
Market cap
$5.72 billion using about 129.47 million Class A shares outstanding, verified within 0.05% of price times share math; note that some data panels display about $11.64 billion, a figure that appears tied to the dual-class total share structure
AI score
58 / 100
Rating
Leading specialty insurance broker with structural E&S market tailwinds, high gross margins, and a strong Q2 2026 earnings beat, but softer adjusted margins, decelerating growth guidance, elevated interest expense, and a dual-class capital structure keep the score mid-range
Trend status
RYAN jumped as much as 16% after the July 30, 2026 earnings report before fading to close at $44.16 on July 31, a 10% weekly and 15% monthly gain, but the stock is still down about 26% over the past year and below the 52-week high near $61, so the short-term trend is bullish while the intermediate trend remains damaged
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Ryan Specialty provides specialty insurance products and services through wholesale brokerage, binding authority, and underwriting management. Clients pay for access to niche E&S markets that standard carriers avoid, creating high-margin, relationship-driven revenue with gross margins above 90%. | High |
| Moat | The moat comes from deep relationships with retail brokers and carriers, specialized underwriting expertise in hard-to-place risks, technology and data advantages in binding authority, and scale in the fragmented wholesale channel. Scale and reputation matter more than patents. | Medium-high |
| Management | CEO Timothy Turner leads a company founded by Patrick G. Ryan Sr., a well-known figure in the insurance industry. Management delivered a Q2 2026 beat and announced a $600 million buyback, but the dual-class equity structure, key-person dependence on the founding team, and a steady M&A pipeline add complexity to the assessment. | Medium-high |
| Financial trend | Q2 2026 revenue rose 7.2% to $916.65 million and adjusted EPS of $0.74 beat estimates, but adjusted operating margin contracted to 19.7% from 22.3% and free cash flow margin fell to about 19.7% from 39% a year earlier. FY2025 revenue was about $3.07 billion with GAAP net income of roughly $63 million. | Medium-high |
| Valuation | At $44.16, trailing GAAP PE near 57x on TTM EPS of $0.77 looks expensive. On forward adjusted EPS of roughly $2.22, the forward PE is about 20x, which is more reasonable for a mid-single-digit grower but leaves limited safety margin if growth or margins disappoint. | Medium |
| Technical trend | RYAN surged as much as 16% after July 30 earnings and closed at $44.16 on July 31, up 10% for the week and 15% for the month, reclaiming its 50-day moving average. The stock remains below the 52-week high near $61 and the all-time high near $77, so the near-term trend is bullish but the longer-term trend is still recovering. | Medium |
| Risk level | Key risks are a turn in the E&S pricing cycle, margin compression, decelerating organic growth, rising interest expense, integration of acquisitions, tax receivable agreement obligations, key-person dependence on the founding team, and a potential hard-landing recession that reduces insurance demand. | High |
| AI confidence | Data confidence is high for current pricing, Q2 2026 results, the buyback, and reported financials. Forecast confidence is medium because GAAP earnings are distorted by non-cash items and the dual-class structure, making normalized earnings estimation less precise. | High data confidence |
| Investment certainty | RYAN screens as a quality compounder with structural tailwinds, but the trailing valuation, margin contraction, and decelerating guidance reduce certainty. Certainty improves if organic growth holds near the high end of guidance, adjusted margins stabilize, and the buyback supports per-share value. | Low to medium |
RYAN AI stock forecast
The RYAN AI stock forecast uses scenario ranges to account for the gap between GAAP and adjusted earnings, the insurance cycle, and M&A execution. Using a normalized adjusted EPS assumption of $2.10, 3-year growth inputs of 12%, 7%, and 0%, and terminal multiples of 26x, 20x, and 14x, the audited model produced bullish value near $76.70, base value near $51.50, and bearish value near $29.40. These are scenario ranges, not price promises. The bull case reflects continued share gains and margin recovery, while the bear case models a hard pricing cycle reversal or a margin spiral.
$65 to $85
More likely if Ryan Specialty sustains organic growth near the high end of guidance or better, stabilizes or expands adjusted operating margin, executes the $600 million buyback, keeps M&A accretive, and the market holds a premium multiple between 24x and 28x on adjusted earnings approaching $2.50 per share.
$42 to $55
More likely if organic growth settles near 5% to 8%, adjusted operating margin stabilizes in the 19% to 21% range, the buyback offsets dilution, and the market values forward adjusted EPS of $2.20 to $2.30 at 18x to 22x.
$24 to $34
More likely if the E&S pricing cycle turns, organic growth slows below 4%, adjusted margins keep falling, a large acquisition underperforms, interest expense rises further, or the stock re-rates toward 12x to 15x on flat or declining adjusted earnings.
RYAN AI technical analysis
RYAN AI technical analysis uses market data available around the August 3, 2026 cutoff. RYAN closed near $44.16 on July 31, 2026 after jumping as much as 16% following the July 30 earnings beat, up about 10% for the week and 15% for the month. The stock reclaimed its 50-day moving average on the rally, but the 200-day moving average remains above the current price, keeping the longer-term trend bearish until that level is reclaimed. TradingView technicals read strong buy on the daily summary, buy on the one-week view, and sell on the one-month view.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $44.16 | July 31, 2026 close from Google Finance, TradingView, and StockStory quote summaries. |
| Immediate support | $42.00 to $43.50 | The early July 2026 consolidation and the post-earnings pullback area form the first support zone on any dip. |
| Key support | $38.50 to $39.50 | The 50-day moving average zone near $38.88, cited as the breakout trigger in a TradingView setup, is the critical secondary support. |
| June recovery low support | $33.00 to $35.00 | The mid-2026 lows that preceded the July rally mark the deeper support area that must hold to preserve the recovery pattern. |
| 52-week low support | $29.28 | The 52-week low near $29.28 is the area where the stock found its strongest buying interest earlier in 2026. |
| Near resistance | $47.00 to $48.50 | The July 31 intraday high of $48.21 marks nearby overhead supply that needs to clear for the rally to extend. |
| Secondary resistance | $50.00 to $52.00 | The post-earnings spike toward $51.19 is the next supply zone; a close above it would signal a stronger trend change. |
| 52-week high | $61.05 (ATH $77.16) | The 52-week high is near $61.05 and the all-time high is $77.16 from April 2025. Full recovery to these levels requires sustained fundamental improvement. |
| 50-day moving average | Estimated near $38.50 to $39.50 | The 50-day MA was reclaimed during the July rally and now acts as support. The exact value depends on source timing. |
| 200-day moving average | Estimated near $48 to $52 | The 200-day MA is likely near or just above the current price, so the long-term trend stays bearish until RYAN holds above this band. |
| Momentum | RSI moved from neutral to overbought after the earnings surge | RSI climbed after the Q2 beat and the stock is near short-term overbought conditions, raising the risk of a pullback before continuation. |
| Volume | Elevated around earnings, above the 2.37 million average | Volume picked up sharply during the earnings move, which supports the near-term bullish case if buying interest continues. |
| Invalidation | Close below $38.50 | A decisive break below the 50-day moving average zone would invalidate the short-term recovery and suggest the rally has failed. |
RYAN AI trading strategy
The RYAN AI trading strategy below is a rules-based research framework, not personal advice. It connects price action with organic growth rates, E&S pricing cycle indicators, M&A announcements, adjusted margin trends, interest expense, buyback execution, and insider buying or selling patterns.
Watch for RYAN to hold above the $42 to $43.50 support zone, then break and close above the $47 to $48.50 resistance on above-average volume while organic growth holds near guidance and adjusted EPS estimates are stable or rising.
A close below $42, organic growth guidance below 5%, or another adjusted margin decline should reduce trend-following confidence. Do not chase a rally into $50+ without a confirmed close above prior supply.
If RYAN pulls back toward the $38.50 to $40 area near its reclaimed 50-day moving average without a fundamental deterioration in the E&S market or a negative guidance revision, compare the entry with the audited base and bearish scenarios before treating the move as attractive.
Do not treat a pullback as automatically mean-reverting if the pricing cycle is turning, adjusted margins keep falling, or interest expense rises faster than expected. Wait for stabilization in volume and price action before entry.
Track organic revenue growth, adjusted operating margin and adjusted EBITDA margin, adjusted EPS, the pace of the $600 million buyback, total M&A spend and integration, net interest expense, share count trends, tax receivable agreement liability, and retail broker and E&S market premium data from industry sources.
Position sizing should reflect that RYAN trades at a premium valuation that can compress quickly if growth slows, margins fall, or the cycle turns. Use the bearish scenario as a reference for worst-case drawdown.
Investment research summary
Customers pay Ryan Specialty for access to niche insurance markets that standard carriers cannot or will not underwrite. The company earns fees and commissions as a wholesale broker, binding authority manager, and underwriting manager, providing essential distribution in the growing E&S segment.
Ryan Specialty benefits from deep broker and carrier relationships, specialized underwriting talent, technology in binding authority, scale in a fragmented wholesale market, and the growing preference for E&S placement as standard carriers tighten terms. The moat is durable but relationship-driven rather than IP-driven.
The thesis fails if the E&S pricing cycle enters a sustained soft market, organic growth slows sharply, adjusted margins keep contracting, a large acquisition destroys value, interest expense overwhelms operating income, the tax receivable agreement becomes a cash drain, or key underwriting talent leaves for competitors.
Timothy Turner and the leadership team have grown Ryan Specialty from a startup in 2010 to a major E&S broker through organic investment and about 40 acquisitions. Founder Patrick G. Ryan Sr. remains active as executive chair. The Q2 2026 beat and the $600 million buyback are constructive, but the capital allocation test is whether they can integrate deals without margin dilution and manage the dual-class structure.
The E&S insurance market continues to grow faster than the standard admitted market, driven by regulatory hardening, climate risk, cyber risk, and standard carrier retrenchment. This structural tailwind benefits wholesale brokers like Ryan Specialty. The industry remains exposed to pricing cycles, consolidation pressure, and technology disruption.
At $44.16, RYAN trades above the audited bearish case and below the base case. Margin of safety is limited because the trailing GAAP PE is approximately 57x, forward adjusted PE is roughly 20x, and the base case depends on margin stabilization and mid-single-digit growth that could fail to materialize if the cycle turns.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| RYAN quote reference | About $44.16 close on July 31, 2026 | Google Finance RYAN:NYSE and TradingView | August 3, 2026 |
| Market capitalization verification | $5.72 billion calculated from $44.16 x 129.47 million Class A shares; tool deviation versus reported value was 0.05%; some panels show about $11.64 billion tied to the dual-class total share count | Pineify financial_rigor.py, Google Finance, and TradingView | August 3, 2026 |
| Shares outstanding | About 129.47 million Class A shares on Google Finance; float about 113.09 million on TradingView | Google Finance and TradingView | August 3, 2026 |
| Q2 2026 earnings summary | Revenue about $916.65 million, up 7.2% year over year; adjusted EPS $0.74 versus $0.60 estimate, about a 23% beat; adjusted EBITDA $326.9 million versus $278.3 million estimate at a 35.7% margin | Google Finance, StockStory, and TradingView | August 3, 2026 |
| FY2025 revenue and GAAP net income | Full-year revenue about $3.07 billion; GAAP net income about $63.4 million; trailing twelve month revenue about $3.18 billion | TradingView financials summary and Google Finance | August 3, 2026 |
| TTM revenue and EPS | TTM revenue about $3.18 billion; TTM GAAP EPS about $0.77; trailing PE near 57x | Google Finance and TradingView | August 3, 2026 |
| Adjusted earnings trend | Q2 2026 adjusted EPS $0.74, up from $0.66 a year earlier; FY2025 adjusted EPS about $2.13; FY2026 consensus adjusted EPS about $2.22, implying low single digit growth | StockStory and TradingView | August 3, 2026 |
| Margin trend | Adjusted operating margin 19.7% in Q2 2026, down from 22.3% a year earlier; free cash flow margin about 19.7%, down from 39%; gross margin above 90% | StockStory and TradingView | August 3, 2026 |
| Valuation metrics verification | PE (TTM) about 57.35x at $44.16 / $0.77; dividend yield 1.18% at $0.52 / $44.16; PS about 1.80x at $44.16 / $24.54 revenue per share | Pineify financial_rigor.py verification | August 3, 2026 |
| Dividend and yield | Quarterly dividend of $0.13 per share; annualized $0.52; dividend yield approximately 1.15% to 1.18% | Google Finance and TradingView | August 3, 2026 |
| Share repurchase program | $600 million share repurchase program announced alongside the July 30, 2026 Q2 results | Stock Titan press release summary | August 3, 2026 |
| Interest expense | Quarterly interest expense near $56 million in the most recent quarter, a continuing drag on GAAP net income | Google Finance quarterly income statement | August 3, 2026 |
| Price range and volume | 52-week range $29.28 to $61.05; all-time high $77.16 (April 2025); average daily volume about 2.37 million shares | Google Finance and TradingView | August 3, 2026 |
| Analyst consensus | 15 analysts: 8 Buy, 6 Hold, 1 Sell; price target range $31 to $55; mean target approximately $44.23; TradingView forecasts page shows a wider range with a consensus near $48 | Google Finance analyst ratings summary and TradingView | August 3, 2026 |
This RYAN AI stock analysis is an informational research tool only and is not investment advice, tax advice, or a recommendation to buy or sell any security. Forecast scenarios are based on available public data as of August 3, 2026, and can be wrong if Ryan Specialty execution, organic growth, adjusted margins, the E&S pricing cycle, M&A results, interest expense, regulation, competition, or market valuation changes.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
